TERESA CAGLE: Open Payments
NPI 1902478852 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,445 in 121 payments from 19 companies in 2025. Trend: 2023 $3,342 · 2024 $3,066 · 2025 $2,445
Food & beverage: $2,445
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $459 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $417 |
| Teva Pharmaceuticals USA, Inc. | 20 | $263 |
| Neurocrine BioSciences, Inc. | 11 | $260 |
| E.R. Squibb & Sons, L.L.C. | 9 | $190 |
| Vanda Pharmaceuticals Inc. | 8 | $173 |
| Alkermes, Inc. | 8 | $137 |
| ABBVIE INC. | 11 | $135 |
| Lundbeck LLC | 4 | $105 |
| Axsome Therapeutics, Inc. | 2 | $62 |
Products named: CAPLYTA, REXULTI, ABILIFY MAINTENA, INGREZZA, COBENFY, FANAPT, AUSTEDO XR, ARISTADA.
Industry payments across GA — which companies pay providers there.
